Developing technology to quickly and efficiently bioprint human tissues at scale is the goal of a new project led by Penn State researchers.
Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter
Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?